95 results on '"Klok, Frederikus A."'
Search Results
2. Computed tomography diagnosis of pulmonary infarction in acute pulmonary embolism
3. Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study
4. Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021
5. Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial
6. Functional limitations 3 and 12 months after venous thromboembolism: a cohort study
7. Splanchnic vein thrombosis in necrotizing pancreatitis: a post-hoc analysis of a nationwide prospective cohort
8. Performance-based outcome measures for assessing physical capacity in patients with pulmonary embolism: A scoping review
9. Incidence and clinical course of chronic thromboembolic pulmonary hypertension with or without a history of venous thromboembolism in Denmark
10. Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review
11. RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study
12. The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis
13. Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
14. Accuracy of physicians’ intuitive risk estimation in the diagnostic management of pulmonary embolism: an individual patient data meta-analysis
15. The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
16. Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism
17. Covariate-specific ROC curve analysis can accommodate differences between covariate subgroups in the evaluation of diagnostic accuracy
18. Long-Term Prognostic Impact of Pulmonary Hypertension After Venous Thromboembolism
19. Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older
20. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism
21. Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review
22. Outcomes of venous thromboembolism care: future directions
23. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study
24. Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism
25. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data
26. Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice
27. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial
28. Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study
29. Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation
30. Treatment and prevention of cancer-associated thrombosis in the Netherlands: A national survey
31. Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
32. Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19
33. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
34. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
35. Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes
36. Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation
37. Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study
38. Illustrated State‐of‐the‐Art Capsules of the ISTH 2022 Congress
39. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study
40. Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
41. Risk of recurrence in women with venous thromboembolism related to estrogen‐containing contraceptives: Systematic review and meta‐analysis
42. Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A systematic review and meta-analysis
43. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
44. Vaccine-induced immune thrombotic thrombocytopenia
45. Identification of chronic thromboembolic pulmonary hypertension on CTPAs performed for diagnosing acute pulmonary embolism depending on level of expertise
46. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
47. Detection of upper extremity deep vein thrombosis by magnetic resonance non‐contrast thrombus imaging
48. Global reporting of pulmonary embolism–related deaths in the World Health Organization mortality database: Vital registration data from 123 countries
49. Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE
50. Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.